TSA increased SMN2 gene expression in a mouse model of spinal muscular atrophy (SMA), and significantly enhanced exon 7 inclusion (the splicing defect) in SMN2 transcripts [60]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.